Literature DB >> 12923071

PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells.

Guizhu Hong1, Andrew Lockhart, Bill Davis, Hassan Rahmoune, Sharon Baker, Liang Ye, Paul Thompson, Yaping Shou, Kevin O'Shaughnessy, Pierre Ronco, John Brown.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-dependent transcription factor that belongs to the nuclear receptor family that plays a critical role in adipocyte differentiation and lipid metabolism. Here we report for the first time that PPARgamma is expressed in human renal cortical collecting ducts (CCD), segments of the nephor involved in regulation of sodium and water homeostasis via action of the epithelial sodium channel (ENaC). ENaC activity is regulated by the hormones aldosterone and insulin, primarily through co-ordinate actions on serum and glucocorticoid regulated kinase 1 (SGK1). We show that SGK1 activity is stimulated by treatment of a human CCD cell line with PPARgamma agonists, paralleled by an increase in SGK1 mRNA that is abolished by pretreatment with a specific PPARgamma antagonist, and that this leads to increased levels of cell surface ENaCalpha. Electrophoretic mobility shift assays suggest that these effects are caused by binding of PPARgamma to a specific response element in the SGK1 promoter. Our results identify SGK1 as a target for PPARgamma and suggest a novel role for PPARgamma in regulation of sodium re-absorption in the CCD via stimulation of ENaC activity. This pathway may play a role in sodium retention caused by activation of PPARgamma in man.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923071     DOI: 10.1096/fj.03-0181fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  31 in total

1.  Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.

Authors:  Emily Borsting; Vicki Pei-Chun Cheng; Chris K Glass; Volker Vallon; Robyn Cunard
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

Review 2.  Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion.

Authors:  George Seki; Yoko Endo; Masashi Suzuki; Hideomi Yamada; Shoko Horita; Toshiro Fujita
Journal:  World J Nephrol       Date:  2012-10-06

3.  Aldosterone regulation of intestinal Na absorption involves SGK-mediated changes in NHE3 and Na+ pump activity.

Authors:  Mark W Musch; Alvaro Lucioni; Eugene B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-18       Impact factor: 4.052

4.  Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes.

Authors:  Karen Wallace; Quan Long; Emma A Fairhall; Keith A Charlton; Matthew C Wright
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

5.  Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.

Authors:  Wenfang Lai; Zhenwei Zheng; Xiaoqin Zhang; Yicong Wei; Kedan Chu; John Brown; Guizhu Hong; Lidian Chen
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

6.  Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1.

Authors:  Natalia Di Pietro; Valentine Panel; Schantel Hayes; Alessia Bagattin; Sunitha Meruvu; Assunta Pandolfi; Lynne Hugendubler; Geza Fejes-Tóth; Aniko Naray-Fejes-Tóth; Elisabetta Mueller
Journal:  Mol Endocrinol       Date:  2009-12-04

7.  Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

Authors:  Michel Komajda; John J V McMurray; Henning Beck-Nielsen; Ramon Gomis; Markolf Hanefeld; Stuart J Pocock; Paula S Curtis; Nigel P Jones; Philip D Home
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

8.  Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors.

Authors:  Tengis S Pavlov; John D Imig; Alexander Staruschenko
Journal:  PPAR Res       Date:  2010-06-14       Impact factor: 4.964

9.  Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.

Authors:  Eileen R Blasi; Jonathan Heyen; Michelle Hemkens; Aileen McHarg; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  PPAR Res       Date:  2009-06-11       Impact factor: 4.964

10.  PPARgamma Agonists: Blood Pressure and Edema.

Authors:  Bonnie L Blazer-Yost
Journal:  PPAR Res       Date:  2009-12-22       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.